Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Neyt

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 2, 2005
An economic evaluation of Herceptin in adjuvant setting: the Breast Cancer International Research Group 006 trialM Neyt, J Albrecht, V Cocquyt
Acta Clinica Belgica|January 13, 2015
Belgian guidelines for budget impact analysesM Neyt, I Cleemput, S Van De Sande, et al.
Revue D'Epidemiologie Et De Sante Publique|March 13, 2013
[Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?]S Stordeur, I Vinck, M Neyt, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 2, 2005
An economic evaluation of Herceptin in adjuvant setting: the Breast Cancer International Research Group 006 trialM Neyt, J Albrecht, V Cocquyt
Acta Clinica Belgica|January 13, 2015
Belgian guidelines for budget impact analysesM Neyt, I Cleemput, S Van De Sande, et al.
Revue D'Epidemiologie Et De Sante Publique|March 13, 2013
[Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?]S Stordeur, I Vinck, M Neyt, et al.
Pageof 1